about
Diagnosis of Morquio Syndrome in Dried Blood Spots Based on a New MRM-MS AssayRecommendations from the international stroke genetics consortium, part 1: standardized phenotypic data collectionGenome-Wide Association Analysis of Young-Onset Stroke Identifies a Locus on Chromosome 10q25 Near HABP2Erythropoietin and the effect of oxygen during proliferation and differentiation of human neural progenitor cells.Fabry disease - underestimated in the differential diagnosis of multiple sclerosis?Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patientsBroad spectrum of Fabry disease manifestation in an extended Spanish family with a new deletion in the GLA geneA novel, highly sensitive and specific biomarker for Niemann-Pick type C1 disease.Cardiac Troponin I: A Valuable Biomarker Indicating the Cardiac Involvement in Fabry Disease.Heritability of young- and old-onset ischaemic stroke.Newborn screening for lysosomal storage disorders in hungary.Journal Club: Time trends in incidence, case fatality, and mortality of intracerebral hemorrhageMulticenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry disease.Neuroradiological, neurophysiological and molecular findings in infantile Krabbe disease: two case reportsDesign and rationale for examining neuroimaging genetics in ischemic stroke: The MRI-GENIE study.Dolichoectasia and Small Vessel Disease in Young Patients With Transient Ischemic Attack and Stroke.Functional and Clinical Consequences of Novel α-Galactosidase A Mutations in Fabry Disease.Integrity of normal-appearing white matter and functional outcomes after acute ischemic stroke.C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber Disease.Enzyme enhancers for the treatment of Fabry and Pompe disease.Perioperative posterior reversible encephalopathy syndrome in 2 pediatric neurosurgery patients with brainstem ependymoma.Structural Integrity of Normal Appearing White Matter and Sex-Specific Outcomes After Acute Ischemic Stroke.White Matter Hyperintensity Volume and Outcome of Mechanical Thrombectomy With Stentriever in Acute Ischemic Stroke.Cerebral Cortical Microinfarcts on Magnetic Resonance Imaging and Their Association With Cognition in Cerebral Amyloid AngiopathyIn search of a putative imaging biomarker for Fabry disease: Go with the flow?How to Organize a Journal Club for Fellows and ResidentsA genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiologyWhite Matter Integrity and Early Outcomes After Acute Ischemic StrokeJournal Club: Florbetapir imaging in cerebral amyloid angiopathy-related hemorrhagesWhite matter hyperintensity burden in acute stroke patients differs by ischemic stroke subtype
P50
Q28397790-ED194FD5-A148-449B-ACCA-ACBBEAACCCD9Q30301140-F8DC7958-36DF-4A8D-954E-2174CD0DCC5AQ30354370-5D0D788C-30F8-4552-8EE1-6913C49717DAQ33761779-B0EE0ED9-BB38-403D-A4E3-FA40ED8198A3Q34981327-ABE87E65-85D1-47BD-95DB-0E2F130912B5Q35053231-9A81C190-DE18-45A1-A936-26A3B4C97458Q35608416-47C6719E-71AA-4D7B-8FC0-B2AED12A2E98Q35775542-2BD440BC-70CD-4139-A090-0975D102B0B2Q36056601-B5B15C5F-28D9-473B-860A-57689FCCC5B1Q36143269-B523DB31-A596-47B6-9CB2-F8AE18BD9A7CQ36590921-5769DB23-DE40-477B-9594-2D91E8D3123FQ36918872-EA3A98D3-4B0B-4E94-B744-E57910090867Q37054755-BC4D9E75-565D-4082-9E7C-C3D826D7DB43Q37262089-72F20B29-40E2-4DE5-B9A5-9030D236DBA2Q38368492-D04887DF-B0B2-473B-ACB0-05AD998F0B11Q38373157-5BC518EC-5840-4D9F-8549-96C3694D4AF5Q38831815-47C60694-1B69-4A75-AC0B-EA1E3C9DB13FQ38851614-F8BC5C89-3E7A-43D4-B669-F73B95319382Q41094126-69AA7A47-7C9E-4E99-B3BB-21CDE0360539Q42018342-20DA08B2-D265-4746-98FC-E9D1FF8B27B8Q46374274-37B42B0C-8CE0-4480-BFF2-47BA45578167Q47582983-290F2C53-14F8-4782-BBE5-253B41BD366BQ47696639-4DA22B81-FB81-4D55-9D91-84B384455C73Q57820711-4FC8F0E9-B32C-4959-B1BD-017D084F81EEQ88376552-85B921B8-DF31-4C3F-BB4F-4124F626E589Q90007462-EEB5F633-505C-4CC8-8734-C77E900C46B7Q91044354-9AEFD38E-C9D2-463C-9DBA-A1618C9635AAQ91261716-D80C7B78-9DB0-4D94-9F02-B308C4B4C527Q91493553-01220E67-3C8B-4A55-AB58-6A9CB5D308A9Q96130221-58968C39-36FF-40A4-8D7B-F4368BD2A708
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Anne-Katrin Giese
@en
Anne-Katrin Giese
@nl
type
label
Anne-Katrin Giese
@en
Anne-Katrin Giese
@nl
prefLabel
Anne-Katrin Giese
@en
Anne-Katrin Giese
@nl
P31
P496
0000-0002-8500-2376